Home > Healthcare > Analytical Instruments > Molecular Analysis > In-situ Hybridization Market

In-situ Hybridization Market Size

  • Report ID: GMI3991
  • Published Date: Apr 2024
  • Report Format: PDF

In-situ Hybridization Market Size

In-situ Hybridization Market size was valued at USD 1.6 billion in 2023 and is estimated to grow at 8.6% CAGR from 2024 to 2032. In-situ hybridization (ISH) is a powerful molecular biology technique used to visualize and locate specific nucleic acid sequences within cells or tissues. The technique allows researchers to detect and localize the presence of specific DNA or RNA sequences in individual cells, providing valuable information about gene expression, gene editing, chromosomal abnormalities, and the spatial distribution of nucleic acids.

 

The increasing technological advancement in the field of in-vitro diagnostics is a significant driving factors for the in-situ hybridization market. For instance, automation of ISH workflows and the availability of digital imaging systems have made the technique more efficient, reducing hands-on time and improving data analysis. This has contributed to the market growth by enhancing workflow productivity and result interpretation.

 

Furthermore, growing prevalence of chronic diseases, rising R&D investments, rising adoption of genetic testing (market size is estimated to account for USD 43 billion by the end of year 2032), increasing demand for precision medicine, government initiatives and funding, and increasing education & awareness, are the promoting factors fostering the growth of the market.

 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of in-situ hybridization reached USD 1.6 billion in 2023 and is set to witness 8.6% CAGR from 2024 to 2032, owing to growing prevalence of chronic diseases, R&D investments, and rising adoption of genetic testing.

Fluorescent in-situ hybridization segment size reached USD 888.8 million in 2023, as it allows for easy visualization and imaging of DNA or RNA targets under a fluorescence microscope.

The U.S. market size is anticipated to grow at 8.2% CAGR during 2024-2032, attributed to the technological advancements in in-situ hybridization.

Agilent Technologies, Inc., Bio-Techne Corporation, Bio-Rad Laboratories, Inc., Bio View Ltd., Danaher Corporation, Merck KGaA, Neogenomics, Inc., PerkinElmer, Inc., Sysmex Corporation and Thermo Fisher Scientific Inc.

In-situ Hybridization Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 292
  • Countries covered: 23
  • Pages: 160
 Download Free Sample